Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

January 8, 2026 – National Institutes of Health (NIH) released the following: ...

A new study published in the Pakistan Journal of Pharmaceutical Science showed that when used as an adjuvant treatment for diabetic foot ulcers or diabetic peripheral neuropathy caused by type ...

Peripheral nerve injury reduces the ability of macrophages to clear dead or dying cells – a process known as efferocytosis – leading to chronic pain Restoring efferocytosis ability reduced neuropathic ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process could help improve recovery ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

Explore feline diabetes management with expert insights from Audrey Cook, BVM&S, MSc, MRCVS, DACVIM (SAIM), DECVIM-CA, DABVP ...

A hidden immune stress switch may be driving chemotherapy nerve pain and scientists have found a way to turn it off.

A research team supported by the National Institutes of Health (NIH) has found that conditions known to cause nerve damage, ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

Separately, Irish medtech company OncoAssure signs collaboration with New York medical school to test prostate cancer product ...